Drug research

Envudeucitinib

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusNCT05966480	ALMS	Phase 2	Active not recruiting	2026-06-23Actual
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque PsoriasisNCT06586112	ALMS	Phase 3	Completed	2025-09-19Actual
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001NCT06588738	ALMS	Phase 3	Completed	2025-09-23Actual

ALMSActive not recruitingPrimary completion: 2026-06-23 · Actual

Trial details

ALMSCompletedPrimary completion: 2025-09-19 · Actual

Trial details

ALMSCompletedPrimary completion: 2025-09-23 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.